Director/PDMR Shareholding
Amlin Plc
FOR IMMEDIATE RELEASE
AMLIN PLC ('Amlin')
RIGHTS ISSUE DIRECTORS' DEALINGS
In accordance with the Directors' intentions stated in the Prospectus relating
to the rights issue of the Company's shares announced on 1 November 2005
('Rights Issue'), and as required by Section 324 of the Companies Act 1985 and
Disclosure Rule 3.1.2R, Amlin announces that, in connection with the Rights
Issue, the following sales of Amlin nil paid New Ordinary Shares of 25p each
('Nil Paid Rights') have been made by Directors and Persons Discharging
Managerial Responsibility ('PDMRs'):
Director/PDMR Nil Paid Date of Price Current Current
Rights sale per shareholding shareholding
sold Nil
Paid
Right Number %
Directors
---------------------------
B D Carpenter (and spouse) 162,764 3/11/05 48p 677,924 0.169
R A Hextall 34,203 3/11/05 48p 136,981 0.034
A W Holt (and spouse) 569,053 3/11/05 48p 2,522,518 0.630
C E L Philipps 62,174 3/11/05 48p 255,488 0.064
Lord Stewartby 10,707 8/11/05 51.5p 46,054 0.011
PDMRs
---------------------------
S C W Beale 64,556 4/11/05 48p 264,084 0.066
J le T Illingworth 44,156 3/11/05 48p 176,841 0.044
The above mentioned Directors and PDMRs intend to subscribe for the following
balances of New Ordinary Shares in the Rights Issue following their sales of Nil
Paid Rights:
Director/PDMR New Ordinary Shares intended
to be subscribed in Rights
Issue
----------------------------------
B D Carpenter (and spouse) 46,428
R A Hextall 9,381
A W Holt (and spouse) 233,566
C E L Philipps (excluding Nil Paid
Rights arising in PEP) 17,246
Lord Stewartby 3,946
PDMRs
----------------------------------
S C W Beale 19,470
J le T Illingworth 12,110
Certain terms used in this announcement are defined and have the same meaning in
the Rights Issue Prospectus.
Enquiries:
Charles Pender 020 7746 1000
Secretary
Amlin plc
10 November 2005
Hoare Govett Limited, which is authorised and regulated in the United Kingdom by
the Financial Services Authority, is acting as sponsor, underwriter, broker and
joint financial adviser to Amlin in connection with the Rights Issue and the
listing of the New Ordinary Shares on the Official List and their admission to
trading on the London Stock Exchange's market for listed securities and will not
be responsible to anyone other than Amlin for providing the protections afforded
to clients of Hoare Govett Limited or for providing advice in relation to the
Rights Issue, proposed listing or admission to trading or contents of this
announcement or any other matters referred to in this announcement.
Lexicon Partners Limited, which is authorised and regulated in the United
Kingdom by the Financial Services Authority, is acting as joint financial
adviser to Amlin in connection with the Rights Issue and the listing of the New
Ordinary Shares on the Official List and their admission to trading on the
London Stock Exchange's market for listed securities and will not be responsible
to anyone other than Amlin for providing the protections afforded to customers
of Lexicon Partners Limited or for providing advice in relation to the Rights
Issue, proposed listing or admission to trading or contents of this announcement
or any other matters referred to in this announcement.
The release, publication or distribution of this announcement in certain
jurisdictions may be restricted by law and therefore persons in such
jurisdictions into which this announcement is released, published or distributed
should inform themselves about and observe such restrictions.
No offer, invitation or inducement to acquire shares or other securities in
Amlin is being made by or in connection with this announcement. Any offer,
invitation or inducement to acquire shares in Amlin will be made solely by means
of the prospectus, published on 2 November 2005, as updated by any supplementary
prospectus, and any decision to keep, buy or sell shares in Amlin should be made
solely on the basis of the information contained in such document(s).
This announcement is not for distribution or transmission, directly or
indirectly, in or into the United States, Canada, Australia, Japan, New Zealand
or the Republic of South Africa and does not constitute, or form part of, an
offer to sell or the solicitation of an offer to subscribe for or buy and any
securities ('Securities'), nor the solicitation of any vote or approval in any
jurisdiction, nor shall there be any sale, issue or transfer of the Securities
referred to in this announcement in any jurisdiction in contravention of
applicable law.
The Securities have not been and will not be registered under the US Securities
Act of 1933, as amended (the 'Securities Act') and may not be offered or sold in
the United States unless registered under the Securities Act or an exemption
from such registration is available. No public offering of Securities of Amlin
is being made in the United States.